RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/30646912http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30646912http://www.w3.org/2000/01/rdf-schema#comment"Tumor immune escape is an important strategy of tumor survival. There are many mechanisms of tumor immune escape, including immunosuppression, which has become a research hotspot in recent years. The programmed death ligand-1/programmed death-1 (PD-L1/PD-1) signaling pathway is an important component of tumor immunosuppression, which can inhibit the activation of T lymphocytes and enhance the immune tolerance of tumor cells, thereby achieving tumor immune escape. Therefore, targeting the PD-L1/PD-1 pathway is an attractive strategy for cancer treatment; however, the therapeutic effectiveness of PD-L1/PD-1 remains poor. This situation requires gaining a deeper understanding of the complex and varied molecular mechanisms and factors driving the expression and activation of the PD-L1/PD-1 signaling pathway. In this review, we summarize the regulation mechanisms of the PD-L1/PD-1 signaling pathway in the tumor microenvironment and their roles in mediating tumor escape. Overall, the evidence accumulated to date suggests that induction of PD-L1 by inflammatory factors in the tumor microenvironment may be one of the most important factors affecting the therapeutic efficiency of PD-L1/PD-1 blocking."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.org/dc/terms/identifier"doi:10.1186/s12943-018-0928-4"xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Deng X."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Ge J."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Jiang X."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Li Y."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Li G."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Li X."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Ma J."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Guo C."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Wang J."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Xiong W."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Wu X."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Xiang B."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Zhou M."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Zeng Z."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/author"Xiong F."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/name"Mol Cancer"xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/pages"10"xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/title"Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape."xsd:string
http://purl.uniprot.org/citations/30646912http://purl.uniprot.org/core/volume"18"xsd:string
http://purl.uniprot.org/citations/30646912http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30646912
http://purl.uniprot.org/citations/30646912http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30646912